Literature DB >> 9207627

In vivo low density lipoprotein oxidation relates to coronary reactivity in young men.

O T Raitakari1, O P Pitkänen, T Lehtimäki, S Lahdenperä, H Iida, S Ylä-Herttuala, J Luoma, K Mattila, T Nikkari, M R Taskinen, J S Viikari, J Knuuti.   

Abstract

OBJECTIVES: This study was undertaken to examine the relation of in vivo low density lipoprotein (LDL) oxidation and other lipid risk factors to coronary reactivity in normal subjects.
BACKGROUND: Experimental studies have shown that oxidized LDL (ox-LDL) particles are injurious to the vascular wall by impairing its normal vasodilator function.
METHODS: We used noninvasive positron emission tomographic (PET) imaging with intravenous dipyridamole to measure coronary flow reserve, a marker of coronary endothelial and smooth muscle function, in 30 healthy men (mean [+/-SD] age 34.4 +/- 3.2 years). As a marker of in vivo LDL oxidation, the autoantibody titer against ox-LDL was measured by the enzyme-linked immunosorbent assay method.
RESULTS: Plasma levels of autoantibody titer against ox-LDL were inversely associated with coronary flow reserve (r = -0.42, p = 0.023). High LDL cholesterol levels (above median > 3.0 mmol/liter) were associated with a low coronary flow reserve only in subjects expressing simultaneously high levels of ox-LDL titer (above median). Subjects with simultaneously high levels of LDL cholesterol and ox-LDL titer had lower coronary flow reserve values than subjects in other groups (3.89 vs. > 5.0 in other groups, p = 0.066).
CONCLUSIONS: These data provide evidence for the role of ox-LDL in affecting the coronary reactivity in vivo and support the concept that oxidative modification of LDL particles provides a mechanism by which high LDL concentrations exhibit injurious effects on the coronary vascular bed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9207627     DOI: 10.1016/s0735-1097(97)00103-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  5 in total

Review 1.  Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.

Authors:  Richard J Woodman; Gerard T Chew; Gerald F Watts
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Preparation of a human standard for determination of the levels of antibodies to oxidatively modified low-density lipoproteins.

Authors:  S Koskinen; C Enockson; M F Lopes-Virella; G Virella
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

3.  Effect of ezetimibe-simvastatine over endothelial dysfunction in dyslipidemic patients: assessment by 13N-ammonia positron emission tomography.

Authors:  Erick Alexanderson; Leonardo García-Rojas; Moisés Jiménez; Rodrigo Jácome; Rodrigo Calleja; Alfonso Martínez; Juan M Ochoa; Aloha Meave; Graciela Alexanderson
Journal:  J Nucl Cardiol       Date:  2010-08-25       Impact factor: 5.952

4.  Cardiovascular magnetic resonance imaging-based computational fluid dynamics/fluid-structure interaction pilot study to detect early vascular changes in pediatric patients with type 1 diabetes.

Authors:  Margaret M Samyn; Ronak Dholakia; Hongfeng Wang; Jennifer Co-Vu; Ke Yan; Michael E Widlansky; John F LaDisa; Pippa Simpson; Ramin Alemzadeh
Journal:  Pediatr Cardiol       Date:  2015-01-11       Impact factor: 1.655

5.  Investigation of serum oxidized low-density lipoprotein IgG levels in patients with angiographically defined coronary artery disease.

Authors:  Mohsen Moohebati; Vahid Kabirirad; Majid Ghayour-Mobarhan; Habibollah Esmaily; Shima Tavallaie; Amir Akhavan Rezayat; Hossein Pourghadamyari; Amirhossein Sahebkar
Journal:  Int J Vasc Med       Date:  2014-02-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.